Cerity Partners LLC Purchases 6,756 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

Cerity Partners LLC boosted its stake in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 20.8% in the 4th quarter, HoldingsChannel.com reports. The firm owned 39,183 shares of the semiconductor company’s stock after buying an additional 6,756 shares during the quarter. Cerity Partners LLC’s holdings in Axcelis Technologies were worth $5,082,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Ronald Blue Trust Inc. lifted its position in shares of Axcelis Technologies by 74.7% in the third quarter. Ronald Blue Trust Inc. now owns 152 shares of the semiconductor company’s stock valued at $25,000 after buying an additional 65 shares during the last quarter. NBC Securities Inc. bought a new position in shares of Axcelis Technologies in the 3rd quarter valued at $28,000. Clearstead Advisors LLC bought a new position in shares of Axcelis Technologies in the 3rd quarter valued at $33,000. C M Bidwell & Associates Ltd. acquired a new stake in shares of Axcelis Technologies during the 3rd quarter valued at $34,000. Finally, Meeder Asset Management Inc. acquired a new stake in shares of Axcelis Technologies during the 1st quarter valued at $35,000. 89.98% of the stock is owned by institutional investors and hedge funds.

Axcelis Technologies Stock Performance

ACLS stock opened at $104.32 on Wednesday. The firm has a market cap of $3.40 billion, a PE ratio of 14.04, a P/E/G ratio of 2.23 and a beta of 1.63. The company has a quick ratio of 2.71, a current ratio of 3.79 and a debt-to-equity ratio of 0.05. The business has a 50 day moving average of $112.13 and a 200-day moving average of $126.50. Axcelis Technologies, Inc. has a 12-month low of $102.36 and a 12-month high of $201.00.

Axcelis Technologies (NASDAQ:ACLS) last posted its quarterly earnings data on Thursday, February 8th. The semiconductor company reported $2.15 EPS for the quarter, beating the consensus estimate of $1.98 by $0.17. Axcelis Technologies had a return on equity of 31.66% and a net margin of 21.78%. The business had revenue of $310.29 million for the quarter, compared to the consensus estimate of $297.92 million. During the same quarter in the prior year, the business earned $1.71 earnings per share. Axcelis Technologies’s revenue for the quarter was up 16.6% on a year-over-year basis. As a group, sell-side analysts expect that Axcelis Technologies, Inc. will post 6.88 earnings per share for the current year.

Insider Activity at Axcelis Technologies

In related news, EVP Douglas A. Lawson bought 500 shares of the company’s stock in a transaction on Friday, February 23rd. The shares were purchased at an average price of $111.04 per share, for a total transaction of $55,520.00. Following the completion of the transaction, the executive vice president now directly owns 19,648 shares in the company, valued at approximately $2,181,713.92. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.14% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. B. Riley Financial cut their target price on Axcelis Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Friday, February 9th. B. Riley decreased their price objective on Axcelis Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a report on Friday, February 9th. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $189.00.

Axcelis Technologies Company Profile

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.